PALBOCICLIB CAPSULES

Pre-LaunchSM

palbociclib

ANDACAPSULE
Lifecycle
Pre-Launch
Clinical Trials
20

Clinical Trials (5)

NCT07123090Phase 2Not Yet Recruiting

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Started Feb 2026
25 enrolled
Metastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more
NCT06962969N/ANot Yet Recruiting

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Started Jun 2025
1,000 enrolled
Advanced or Metastatic Breast Cancer
NCT06843967Phase 1/2Recruiting

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Started Feb 2025
NCT07096024N/ACompleted

A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

Started Jan 2025
1,772 enrolled
Breast Neoplasms
NCT05912933N/ACompleted

A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Started Aug 2024
733 enrolled
Breast Cancer